About

We specialize in the field of systems biology with a primary focus on combating ageing and age-related diseases. We translate our research at (among others) on-demand screening assays (both cell-free and cell-based, as well as at in vivo experimental models) aiming to reveal bioactive natural products and/or small molecules with anti-ageing and/or anti-age-related diseases (e.g., cancer, neurodegeneration, etc.) activity. We also aim to offer comprehensive solutions for the commercialization of novel bioactive natural products in the cosmeceuticals, dietary supplements and pharmaceuticals industry.

Solution & Product

By exploiting the uniquely combined expertise of GenCell-TSBiotech founders in the fields of natural products screening, molecular-cellular ageing and age-related diseases, the company will offer disruptive innovation at the discovery of novel bioactive natural products from different areas of the biosphere and/or synthetic small molecules against ageing or age-related diseases. We will provide customer-based screening services of natural products and/or synthetic pure compounds in a high-throughput mode against a wide variety of biological targets; will develop methods/assays to measure biological age (from biomarkers to clocks) and will also introduce novel senotherapeutics (senolytics and/or senomorphics). GenCell-TSBiotech will also valorize its portfolio of bioactive substances for the development of innovative cosmeceuticals, neutraceuticals or pharmaceuticals. We will act on our belief of high standards, integrity, and ethical behavior in order to deliver exceptional results.

Innovation & Scalability

Given that most Biotech-Pharma companies have over the years reduced or even eliminated their natural products related R&D activities, we will offer our clients access to a broad range of high-capacity screening technologies, tools and in vitro, cell-based or in vivo experimental platforms for the systematic bio-guided screening of natural products and/or small molecules. Our tools and technologies will develop with no bias towards target families, biological topics, or models. We will support all stages of a developing project, including assay adaptation, high-throughput screening, and (if needed) chemical optimization of the ‘hit’ compounds. We foresee that the screening methods and the existing know how of the founding members of GenCell-TSBiotech will facilitate the elimination of false positives while in parallel supporting the selection of high value compounds for further optimization. We will ensure that data generated in screening campaigns are reliable, reproducible and comparable, thereby helping to also meet the objective of setting standards in early bioactive natural products discovery and preclinical research. Further we will develop innovative methods/assays to (among others) measure biological age and will also introduce novel senotherapeutics (senolytics and/or senomorphics). Finally, GenCell-TSBiotech will valorize its portfolio of bioactive substances for the development of innovative personalized cosmeceuticals, neutraceuticals or pharmaceuticals.

Traction & achievements

Initial discussions for strategic collaborations and contracts with Greek and International companies as well as with other funding agencies. Our initial progress and build-up momentum will be achieved by being part of the extended network of our partner(s) as well as by seeking new contracts with companies in Greece and abroad. At the same time, we intend to participate in National/International Research Programs as a mean of increasing cooperation-interaction with the Academy and also with raw material providing companies or end-users of our products-services. Research Programs are an "intermediate target market" for the development of a multi-level grid of potential customers, partners and economies of scale along with a robust portfolio of clients. The development of new products is in progress; in this field the complementarity of Pharmagnose S.A. and GenCell-TSBiotech will be further enhanced by the partnership with additional key specialties.

Team & Why Us

GenCell-TSBiotech business development will focus on (four Ps), place, promotion, product, and price. The strategy to be applied for selling products/services will include all traditional and digital channels for reaching potential clients. We will mainly operate in the cosmetics, food supplements, pharma- and biotech industries and sell goods and services that can be categorized as part(s) of these industries. The founders are ready to launch-advertise GenCell-TSBiotech at the targeted industries players (cosmetics, food supplements, pharma- and biotech-) globally and also the governmental and consumers agencies. The founding members of GenCell-TSBiotech will also exploit their existing networks and collaborative National/International agents to promote the innovative products/services of GenCell-TSBiotech.

Funding Needs

Given the lack of companies in Greece with similar specialization, business portfolio and know-how, the growth potential of GenCell-TSBiotech is significant. The development of the company in terms of research services will depend on the renewal and acquisition of new and modern equipment and the employment of highly-skilled personnel, which will help to maintain an advantage over competing companies, and to offer innovative and quality services. Regarding production and marketing of offered services and/or products the level and capacity of production will be critical for expansion from a customer based level to large (e.g. an international cosmetics company) clients. We seek funding from investors, public or private funds, the industry, etc.